BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
2.150
+0.010 (0.47%)
Sep 15, 2025, 3:37 PM EDT - Market open
BioCardia Market Cap
BioCardia has a market cap or net worth of $12.47 million as of September 15, 2025. Its market cap has increased by 138.72% in one year.
Market Cap
12.47M
Enterprise Value
12.27M
1-Year Change
138.72%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since October 26, 2016, BioCardia's market cap has decreased from $29.07M to $12.47M, a decrease of -57.10%. That is a compound annual growth rate of -9.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 12.41M | 24.22% |
| Dec 31, 2024 | 9.99M | -36.30% |
| Dec 29, 2023 | 15.69M | -62.55% |
| Dec 30, 2022 | 41.90M | 28.00% |
| Dec 31, 2021 | 32.73M | -33.47% |
| Dec 31, 2020 | 49.20M | 95.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |